You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Consultation: Draft TGA approach to disclosure of commercially confidential information (CCI)
This consultation closed on 29 August 2013
The TGA sought comments from interested parties on the paper Draft TGA approach to disclosure of commercially confidential information (CCI).
- Consultation: Draft TGA approach to disclosure of commercially confidential information (CCI) (pdf,450kb)
- Consultation: Draft TGA approach to disclosure of commercially confidential information (CCI) (Microsoft Word,485kb)
Document released for consultation on Thursday, 27 June 2013.
Interested parties should respond by close of business Thursday, 29 August 2013.
Feedback will be released following consideration of submissions. (see What will happen).
About the consultation
- The purpose was to provide feedback to the TGA on the content of a document which outlines how it defines "commercially confidential information" and its approach to the disclosure of that information.
- The views of consumers, industry, sponsors and health care professionals and the public general will be important in ensuring that the final version of the document covers all relevant matters and deals with any issues and concerns identified in comments received.
- It should be noted that the document is in a draft form to indicate that it does not represent the TGA's final views.
See: Submissions received
Comments are invited on all aspects of the draft paper.
What will happen
All comments received will be reviewed by the TGA and feedback will be provided through the TGA's Internet site.
A final version of the document that takes account of those comments will be published on the TGA website.
All comments submitted before the closing date will be published on the TGA website unless marked confidential. Any confidential material contained within comments should be provided under a separate cover and clearly marked 'IN CONFIDENCE'. Reasons for a claim to confidentiality must be included in the space provided on the TGA comment coversheet.
For comments provided by individuals, all personal details other than your name will be removed from your submission before it is published on the TGA's website.
A list of those who provided comments will be also published. If you do not wish to be identified with your comments you must specifically request this in the space provided on the coversheet.
Any questions relating to the provision of comments on the paper should be directed by email to email@example.com.